Cholangitis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
| (14 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{FH}} | |||
{{CMG}}; {{AE}} {{FH}}, {{ADS}} | |||
{{Cholangitis}} | {{Cholangitis}} | ||
==Overview== | ==Overview== | ||
[[Cholangitis]] is most prevalent in adults, with roughly 20% of the population suffering from some form of [[abdominal pain]] from [[gallstones]] passing through the [[bile duct]] into the [[digestive tract]]. | [[Cholangitis]] is most [[Prevalence|prevalent]] in adults, with roughly 20% of the population suffering from some form of [[abdominal pain]] from [[gallstones]] passing through the [[bile duct]] into the [[digestive tract]]. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
*Within a span of ten years, 15–26% of people will suffer at least one episode of [[biliary colic]] | *Within a span of ten years, 15–26% of people will suffer at least one episode of [[biliary colic]] ([[abdominal pain]] due to the passage of [[gallstones]] through the [[bile duct]] into the [[Gastrointestinal tract|digestive tract]]).<ref name="pmid10381713">{{cite journal |vauthors=Bateson MC |title=Fortnightly review: gallbladder disease |journal=BMJ |volume=318 |issue=7200 |pages=1745–8 |year=1999 |pmid=10381713 |pmc=1116086 |doi= |url=}}</ref> | ||
*2–3% of people will develop complications of obstruction in the form of acute cholangitis. | *2–3% of people will develop complications of obstruction in the form of acute cholangitis. | ||
*The prevalence of | *The [[prevalence]] of [[gallstones]] increases with age and [[body mass index]]. | ||
*The risk is also increased in those who lose weight rapidly (after [[bariatric surgery]], for example) due to alterations in the composition of the [[bile]] that makes it prone to form stones. | |||
===Mortality rate=== | |||
*In 1980, the [[mortality rate]] of acute cholangitis was more than 50000 per 100,000 individuals; 10000-30000 per 100,000 individuals in 1981-1991; 2700-10000 per 100,000 individuals after the year 2000.<ref name="pmid2218831">{{cite journal| author=Thompson JE, Pitt HA, Doty JE, Coleman J, Irving C| title=Broad spectrum penicillin as an adequate therapy for acute cholangitis. | journal=Surg Gynecol Obstet | year= 1990 | volume= 171 | issue= 4 | pages= 275-82 | pmid=2218831 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2218831 }} </ref><ref name="pmid23307004">{{cite journal| author=Kimura Y, Takada T, Strasberg SM, Pitt HA, Gouma DJ, Garden OJ et al.| title=TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. | journal=J Hepatobiliary Pancreat Sci | year= 2013 | volume= 20 | issue= 1 | pages= 8-23 | pmid=23307004 | doi=10.1007/s00534-012-0564-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23307004 }} </ref><ref name="pmid18769362">{{cite journal| author=Salek J, Livote E, Sideridis K, Bank S| title=Analysis of risk factors predictive of early mortality and urgent ERCP in acute cholangitis. | journal=J Clin Gastroenterol | year= 2009 | volume= 43 | issue= 2 | pages= 171-5 | pmid=18769362 | doi=10.1097/MCG.0b013e318157c62c | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18769362 }} </ref> | |||
===Age=== | ===Age=== | ||
*The condition mostly occurs in adults, with a reported median age at onset of 50-60 years.<ref name="pmid10381713">{{cite journal |vauthors=Bateson MC |title=Fortnightly review: gallbladder disease |journal=BMJ |volume=318 |issue=7200 |pages=1745–8 |year=1999 |pmid=10381713 |pmc=1116086 |doi= |url=}}</ref> | *The condition mostly occurs in [[Adult|adults]], with a reported median age at onset of 50-60 years.<ref name="pmid10381713">{{cite journal |vauthors=Bateson MC |title=Fortnightly review: gallbladder disease |journal=BMJ |volume=318 |issue=7200 |pages=1745–8 |year=1999 |pmid=10381713 |pmc=1116086 |doi= |url=}}</ref> | ||
===Gender=== | ===Gender=== | ||
*Gallstones are slightly more common in women than in men, and pregnancy increases the risk further.<ref name="pmid10381713">{{cite journal |vauthors=Bateson MC |title=Fortnightly review: gallbladder disease |journal=BMJ |volume=318 |issue=7200 |pages=1745–8 |year=1999 |pmid=10381713 |pmc=1116086 |doi= |url=}}</ref> | *[[Gallstones]] are slightly more common in women than in men, and [[pregnancy]] increases the risk further.<ref name="pmid10381713">{{cite journal |vauthors=Bateson MC |title=Fortnightly review: gallbladder disease |journal=BMJ |volume=318 |issue=7200 |pages=1745–8 |year=1999 |pmid=10381713 |pmc=1116086 |doi= |url=}}</ref> | ||
*The increased prevalence of gallstones in women is due to hormonal imbalance between [[estrogen]] and [[progesterone]]. | |||
===Race=== | ===Race=== | ||
* | *There is no racial predilection to cholangitis. | ||
===Developed | ===Developed countries=== | ||
*In Western countries, about | *In Western countries, about 15000 per 100,000 individuals have [[gallstones]] in their [[gallbladder]], but the majority are unaware of this and have no [[symptoms]].<ref name="pmid10381713">{{cite journal |vauthors=Bateson MC |title=Fortnightly review: gallbladder disease |journal=BMJ |volume=318 |issue=7200 |pages=1745–8 |year=1999 |pmid=10381713 |pmc=1116086 |doi= |url=}}</ref> | ||
*Incidence rates range between 0.41 and 1.2 per 100,000 | *[[Incidence (epidemiology)|Incidence]] rates range between 0.41 and 1.2 per 100,000 people per year.<ref name="urlThe prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population | BMC Gastroenterology | Full Text">{{cite web |url=http://bmcgastroenterol.biomedcentral.com/articles/10.1186/1471-230X-11-83 |title=The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population | BMC Gastroenterology | Full Text |format= |work= |accessdate=}}</ref> | ||
===Underdeveloped | ===Underdeveloped countries=== | ||
*[[Parasites]], specifically including the species Ascaris, Opisthorchis, Clonorchis, Fasciola and Echinococcus, are commonly associated with cholangitis outside of the United States.<ref name="urlRadioGraphics: Biliary Infections: Spectrum of Imaging Findings and Management">{{cite web |url=http://pubs.rsna.org/doi/abs/10.1148/rg.297095051 |title=RadioGraphics: Biliary Infections: Spectrum of Imaging Findings and Management |format= |work= |accessdate=}}</ref> | *[[Parasites]], specifically including the species ''[[Ascaris]]'', ''[[Opisthorchis felineus|Opisthorchis]]'', ''[[Clonorchis sinensis|Clonorchis]]'', ''[[Fasciola gigantica|Fasciola]]'' and ''[[Echinococcus]]'', are commonly associated with cholangitis outside of the United States.<ref name="urlRadioGraphics: Biliary Infections: Spectrum of Imaging Findings and Management">{{cite web |url=http://pubs.rsna.org/doi/abs/10.1148/rg.297095051 |title=RadioGraphics: Biliary Infections: Spectrum of Imaging Findings and Management |format= |work= |accessdate=}}</ref> | ||
**Ascaris is thought to be the etiologic agent of recurrent pyogenic cholangitis | **''[[Ascaris]]'' is thought to be the etiologic agent of recurrent pyogenic cholangitis found in Hong Kong, Southeast Asia, Columbia, Italy, and South Africa. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:FinalQCRequired]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Surgery]] | |||
Latest revision as of 20:54, 29 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farwa Haideri [2], Amandeep Singh M.D.[3]
|
Cholangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cholangitis epidemiology and demographics |
|
Risk calculators and risk factors for Cholangitis epidemiology and demographics |
Overview
Cholangitis is most prevalent in adults, with roughly 20% of the population suffering from some form of abdominal pain from gallstones passing through the bile duct into the digestive tract.
Epidemiology and Demographics
Prevalence
- Within a span of ten years, 15–26% of people will suffer at least one episode of biliary colic (abdominal pain due to the passage of gallstones through the bile duct into the digestive tract).[1]
- 2–3% of people will develop complications of obstruction in the form of acute cholangitis.
- The prevalence of gallstones increases with age and body mass index.
- The risk is also increased in those who lose weight rapidly (after bariatric surgery, for example) due to alterations in the composition of the bile that makes it prone to form stones.
Mortality rate
- In 1980, the mortality rate of acute cholangitis was more than 50000 per 100,000 individuals; 10000-30000 per 100,000 individuals in 1981-1991; 2700-10000 per 100,000 individuals after the year 2000.[2][3][4]
Age
Gender
- Gallstones are slightly more common in women than in men, and pregnancy increases the risk further.[1]
- The increased prevalence of gallstones in women is due to hormonal imbalance between estrogen and progesterone.
Race
- There is no racial predilection to cholangitis.
Developed countries
- In Western countries, about 15000 per 100,000 individuals have gallstones in their gallbladder, but the majority are unaware of this and have no symptoms.[1]
- Incidence rates range between 0.41 and 1.2 per 100,000 people per year.[5]
Underdeveloped countries
- Parasites, specifically including the species Ascaris, Opisthorchis, Clonorchis, Fasciola and Echinococcus, are commonly associated with cholangitis outside of the United States.[6]
- Ascaris is thought to be the etiologic agent of recurrent pyogenic cholangitis found in Hong Kong, Southeast Asia, Columbia, Italy, and South Africa.
References
- ↑ 1.0 1.1 1.2 1.3 Bateson MC (1999). "Fortnightly review: gallbladder disease". BMJ. 318 (7200): 1745–8. PMC 1116086. PMID 10381713.
- ↑ Thompson JE, Pitt HA, Doty JE, Coleman J, Irving C (1990). "Broad spectrum penicillin as an adequate therapy for acute cholangitis". Surg Gynecol Obstet. 171 (4): 275–82. PMID 2218831.
- ↑ Kimura Y, Takada T, Strasberg SM, Pitt HA, Gouma DJ, Garden OJ; et al. (2013). "TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis". J Hepatobiliary Pancreat Sci. 20 (1): 8–23. doi:10.1007/s00534-012-0564-0. PMID 23307004.
- ↑ Salek J, Livote E, Sideridis K, Bank S (2009). "Analysis of risk factors predictive of early mortality and urgent ERCP in acute cholangitis". J Clin Gastroenterol. 43 (2): 171–5. doi:10.1097/MCG.0b013e318157c62c. PMID 18769362.
- ↑ "The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population | BMC Gastroenterology | Full Text".
- ↑ "RadioGraphics: Biliary Infections: Spectrum of Imaging Findings and Management".